In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects

Journal of Cardiovascular Pharmacology
Patrick GautierDino Nisato

Abstract

SSR149744C (SSR, 2-butyl-3-[4-[3-(dibutylamino)pro-pyl]benzoyl]-1-benzofuran-5-carboxylate isopropyl fumarate), is a new non-iodinated benzofuran derivative. The aim of this study was to evaluate in vivo its electrophysiological, hemodynamic, and anti-adrenergic properties and to determine its mechanism of action using in vitro studies. In chloralose-anesthetized dogs, SSR149744C (1-10 mg/kg i.v.) prolonged the sinus cycle length, A-H interval, Wenckebach cycle length, atrial effective refractory period (ERP), and atrio-ventricular node ERP in a dose-dependent manner without change of ventricular ERP and HV, QRS, or QTc intervals. Arterial blood pressure and ventricular inotropism were slightly decreased. SSR149744C, which has no or low affinity for alpha 1 and beta 1 adrenergic and angiotensin II AT1 receptors, reduced isoproterenol-induced tachycardia and phenylephrine- or angiotensin II-induced hypertension in anaesthetized dogs. In guinea pig papillary muscle, SSR149744C did not modify the resting potential, action potential amplitude and duration, but reduced the dV/dt max of the depolarization phase in a frequency-dependent manner. In isolated guinea pig cardiomyocytes and transfected CHO cells, SSR149744C (0.01-30 microM...Continue Reading

References

Jan 15, 1976·Biochemical Pharmacology·P Polster, J Broekhuysen
Mar 1, 1989·Progress in Cardiovascular Diseases·H A Kopelman, L N Horowitz
Sep 1, 1988·European Journal of Pharmacology·A VarróB Surawicz
Jun 19, 1985·European Journal of Pharmacology·A VarroB Surawicz
Aug 1, 1970·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Oct 1, 1984·Circulation Research·A O GrantH C Strauss
Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams
Jan 1, 1983·Pflügers Archiv : European journal of physiology·J W MasonB G Katzung
May 1, 1995·Annals of Internal Medicine·P J Podrid
Feb 1, 1995·Journal of Cardiovascular Pharmacology·A ManningP Chatelain
Jul 1, 1997·Cardiovascular Research·I KodamaJ Toyama
Sep 7, 2000·Cardiovascular Research·M R BoyettI Kodama
Dec 16, 2000·Journal of Cardiovascular Pharmacology·E GuillemareP Gautier
Jun 27, 2001·Circulation·L A Moyé
Jul 14, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh, J S Sarma
Jan 28, 2003·Journal of Cardiovascular Pharmacology·Patrick GautierDino Nisato
Aug 2, 2003·Journal of Cardiovascular Electrophysiology·Nathalie LalevéeSylvain Richard
Sep 23, 2003·Circulation Research·David FedidaDavid R Van Wagoner

❮ Previous
Next ❯

Citations

Feb 1, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Roman BogdanHartmut Ruetten
Jul 19, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Heinz GoegeleinHartmut Ruetten
Oct 23, 2009·Current Treatment Options in Cardiovascular Medicine·Kapil Kumar, Peter J Zimetbaum
May 3, 2013·Vascular Health and Risk Management·Yukiomi Tsuji, Dobromir Dobrev
Aug 30, 2008·Clinical Endocrinology·T S HanM P J Vanderpump
Dec 21, 2010·Annals of Medicine·Pasquale SantangeliAndrea Natale
Sep 12, 2007·Expert Opinion on Therapeutic Targets·Deepak Bhakta, John M Miller
Nov 2, 2014·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Axel LoeweGunnar Seemann
Oct 22, 2009·Circulation. Arrhythmia and Electrophysiology·Pamela K Mason, John P DiMarco
Sep 1, 2007·Current Opinion in Cardiology·Suveer BagweJoe Bissett
Oct 26, 2010·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Dominique AbelaWilliam S Webster
Feb 16, 2012·Journal of Applied Toxicology : JAT·Sebastian PolakAleksander Mendyk
Oct 12, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Dierk ThomasNiels Voigt
Sep 21, 2013·Current Cardiology Reports·Kapil Kumar, Peter J Zimetbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.